Sucanon

Sucanon is an orally administered insulin-sensitizing drug and herbal‑derived medication developed for the treatment of type 2 diabetes mellitus. It is described as a natural‑ingredient product that increases the sensitivity of liver, adipose, and skeletal muscle tissues to endogenous insulin, thereby improving glucose uptake and lowering blood glucose levels, and has been clinically studied in non‑insulin‑dependent (type 2) diabetic patients in Brazil and China.[1][3][7][9] Initially marketed and positioned as a neutraceutical or herbal dietary supplement, the product was later classified by the U.S. FDA as a drug based on the pharmacological profile of its active ingredient; it has been approved or marketed for type 2 diabetes in countries including Mexico (over‑the‑counter), Peru and China (by prescription), and is now being commercialized and further developed by companies such as PharmaRoth Labs and Genix Pharmaceuticals.[1][5][7][9][12]

Brand names

Sucanon